Hormonal therapy in breast cancer: A model disease for the personalization of cancer care

► There are a number of prognostic assays to predict outcome in ER+ breast cancers. ► Treatments include tamoxifen, ovarian suppression, and aromatase inhibitors. ► Therapy should be individualized with regards to risk and benefit.